B Meier

Summary

Country: Switzerland

Publications

  1. ncbi Pharmacological activities of Vitex agnus-castus extracts in vitro
    B Meier
    Zeller AG, Herbal Medicinal Products, Romanshorn, Switzerland
    Phytomedicine 7:373-81. 2000
  2. ncbi [From medicinal plant to phytotherapeutic drug]
    B Meier
    Ther Umsch 59:275-82. 2002
  3. ncbi Comparing phytopharmaceuticals: the example of St. John's Wort
    B Meier
    Zeller AG, Herbal Medicinal Products Romanshorn, Switzerland
    Adv Ther 18:35-46. 2001
  4. ncbi Absorbance data of hypericin and pseudohypericin used as reference compounds for medicinal plant analysis
    A Wirz
    Department of Applied BioSciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich,
    Pharmazie 56:52-7. 2001
  5. ncbi [Referral pattern of the heart catheterization laboratory at the Bern Island University Hospital]
    F Muller
    Abteilung fur Kardiologie, Inselspital Bern
    Praxis (Bern 1994) 90:917-24. 2001
  6. ncbi [Efficacy of tea blends in the treatment of dyspeptic disorders--an application observation]
    F Iten
    , , Switzerland
    Forsch Komplementarmed Klass Naturheilkd 9:277-82. 2002
  7. ncbi Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks
    M Schwerzmann
    Department of Cardiology, University Hospital, Bern, Switzerland
    Neurology 62:1399-401. 2004

Collaborators

  • R Saller
  • M Schwerzmann
  • F Iten
  • A Wirz
  • F Muller
  • S Windecker
  • A Wahl
  • K Nedeltchev
  • S Wiher
  • H P Mattle
  • C Seiler
  • O Sticher

Detail Information

Publications7

  1. ncbi Pharmacological activities of Vitex agnus-castus extracts in vitro
    B Meier
    Zeller AG, Herbal Medicinal Products, Romanshorn, Switzerland
    Phytomedicine 7:373-81. 2000
    ..Our results indicate a dopaminergic effect of Vitex agnus-castus extracts and suggest additional pharmacological actions via opioid receptors...
  2. ncbi [From medicinal plant to phytotherapeutic drug]
    B Meier
    Ther Umsch 59:275-82. 2002
    ..Nevertheless, the quality of medicinal preparations from plants can be guaranteed if the raw material, the mode of preparation and the end product are well defined by the manufacturer...
  3. ncbi Comparing phytopharmaceuticals: the example of St. John's Wort
    B Meier
    Zeller AG, Herbal Medicinal Products Romanshorn, Switzerland
    Adv Ther 18:35-46. 2001
    ..If phytopharmaceuticals are to be compared with one another, the scope of consideration cannot be limited to single components. The comparison must be carried out comprehensively...
  4. ncbi Absorbance data of hypericin and pseudohypericin used as reference compounds for medicinal plant analysis
    A Wirz
    Department of Applied BioSciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich,
    Pharmazie 56:52-7. 2001
    ..The decrease of the coefficients by water addition was found to be the same for hypericin and pseudohypericin. It was concluded that hypericin and pseudohypericin reveal the same homoassociation behavior...
  5. ncbi [Referral pattern of the heart catheterization laboratory at the Bern Island University Hospital]
    F Muller
    Abteilung fur Kardiologie, Inselspital Bern
    Praxis (Bern 1994) 90:917-24. 2001
    ..The indications for coronary angiography were found to be appropriate in virtually all cases. Demographic variables and procedure results are in keeping with comparable studies...
  6. ncbi [Efficacy of tea blends in the treatment of dyspeptic disorders--an application observation]
    F Iten
    , , Switzerland
    Forsch Komplementarmed Klass Naturheilkd 9:277-82. 2002
    ..However, due to the limited observation time, no final conclusion could be given concerning long-term compatibility...
  7. ncbi Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks
    M Schwerzmann
    Department of Cardiology, University Hospital, Bern, Switzerland
    Neurology 62:1399-401. 2004
    ..2 +/- 0.7 vs 0.4 +/- 0.4 per month; p = 0.006). PFO closure did not have an effect on headache frequency in patients with nonmigraine headaches (1.4 +/- 0.9 vs 1.0 +/- 0.9 per month; p = NS)...